Erratum: CCL16 maintains stem cell-like properties in breast cancer by activating CCR2/GSK3β/β-catenin/OCT4 axis: Erratum.

[This corrects the article DOI: 10.7150/thno.51000.]. © The author(s).

In our article 1, there were misplaced images in Figure 7E and Figure 8D, respectively. The corrected version is provided here:

Figure 7

E. Immunohistochemistry staining of CCR2, p-AKT, p-GSK3β, β-catenin and OCT4 in each group tumors was performed. Representative images were shown. Scale bars: 50 μm.

Figure 8

D. The representative luciferase images showing 231-luci tumors of each group on Day 12 (before XAV939 administration) and Day 60 (after XAV939 administration).

The correction made in this erratum does not affect the original conclusions. The authors apologize for any inconvenience or misunderstanding that this error may have caused.